Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by Loring Wolcott & Coolidge Fiduciary Advisors LLP MA

Loring Wolcott & Coolidge Fiduciary Advisors LLP MA decreased its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 20.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 13,811 shares of the pharmacy operator’s stock after selling 3,525 shares during the quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA’s holdings in Walgreens Boots Alliance were worth $361,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Dark Forest Capital Management LP boosted its position in shares of Walgreens Boots Alliance by 6.5% during the 3rd quarter. Dark Forest Capital Management LP now owns 29,409 shares of the pharmacy operator’s stock valued at $654,000 after acquiring an additional 1,804 shares during the last quarter. Deutsche Bank AG lifted its position in Walgreens Boots Alliance by 36.2% in the third quarter. Deutsche Bank AG now owns 2,170,347 shares of the pharmacy operator’s stock valued at $48,269,000 after buying an additional 576,534 shares during the last quarter. Van ECK Associates Corp lifted its position in Walgreens Boots Alliance by 28.2% in the third quarter. Van ECK Associates Corp now owns 129,191 shares of the pharmacy operator’s stock valued at $2,873,000 after buying an additional 28,400 shares during the last quarter. Allspring Global Investments Holdings LLC lifted its position in Walgreens Boots Alliance by 3.4% in the third quarter. Allspring Global Investments Holdings LLC now owns 1,444,686 shares of the pharmacy operator’s stock valued at $32,130,000 after buying an additional 47,071 shares during the last quarter. Finally, Vanguard Group Inc. lifted its position in Walgreens Boots Alliance by 14.5% in the third quarter. Vanguard Group Inc. now owns 86,675,198 shares of the pharmacy operator’s stock valued at $1,927,656,000 after buying an additional 10,962,030 shares during the last quarter. Institutional investors and hedge funds own 58.59% of the company’s stock.

Insider Buying and Selling

In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari bought 3,000 shares of Walgreens Boots Alliance stock in a transaction on Thursday, April 11th. The stock was bought at an average price of $18.05 per share, with a total value of $54,150.00. Following the completion of the acquisition, the director now owns 3,000 shares in the company, valued at $54,150. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari bought 3,000 shares of Walgreens Boots Alliance stock in a transaction on Thursday, April 11th. The stock was bought at an average price of $18.05 per share, with a total value of $54,150.00. Following the completion of the acquisition, the director now owns 3,000 shares in the company, valued at $54,150. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Valerie B. Jarrett bought 4,456 shares of Walgreens Boots Alliance stock in a transaction on Monday, January 29th. The stock was acquired at an average cost of $22.44 per share, with a total value of $99,992.64. Following the acquisition, the director now owns 4,456 shares of the company’s stock, valued at approximately $99,992.64. The disclosure for this purchase can be found here. Insiders purchased a total of 13,456 shares of company stock valued at $270,423 over the last three months. 17.40% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on WBA shares. TheStreet raised shares of Walgreens Boots Alliance from a “d+” rating to a “c-” rating in a research report on Monday, January 8th. HSBC reissued a “reduce” rating and set a $20.00 price target (down previously from $27.00) on shares of Walgreens Boots Alliance in a research report on Tuesday, February 20th. Morgan Stanley reduced their price target on shares of Walgreens Boots Alliance from $21.00 to $20.00 and set an “underweight” rating on the stock in a research report on Monday, April 1st. Raymond James reissued a “market perform” rating on shares of Walgreens Boots Alliance in a research report on Tuesday, March 26th. Finally, Bank of America reduced their price target on shares of Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating on the stock in a research report on Tuesday, March 26th. Four research analysts have rated the stock with a sell rating, ten have issued a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $24.36.

Walgreens Boots Alliance Stock Performance

Shares of WBA traded down $0.05 during mid-day trading on Tuesday, reaching $18.17. 4,062,051 shares of the company’s stock were exchanged, compared to its average volume of 13,986,867. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.66 and a quick ratio of 0.32. The stock has a market capitalization of $15.68 billion, a PE ratio of -2.60, a price-to-earnings-growth ratio of 1.13 and a beta of 0.73. The business’s fifty day simple moving average is $20.33 and its 200-day simple moving average is $21.89. Walgreens Boots Alliance, Inc. has a 52-week low of $17.51 and a 52-week high of $35.54.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share for the quarter, topping the consensus estimate of $0.82 by $0.38. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. The firm had revenue of $37.05 billion during the quarter, compared to the consensus estimate of $35.86 billion. During the same period last year, the company earned $1.16 earnings per share. The company’s revenue for the quarter was up 6.3% on a year-over-year basis. On average, equities research analysts expect that Walgreens Boots Alliance, Inc. will post 3.23 earnings per share for the current year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.